Gene · 57016
Papers1,760
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,760
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model. | Heliyon | 2024 | 38317886 | PubTator, text mining | PubMed |
| A Composite Blood Biomarker Including AKR1B10 and Cytokeratin 18 for Progressive Types of Nonalcoholic Fatty Liver Disease. | Diabetes Metab J | 2024 | 38311058 | PubTator, text mining | PubMed |
| Insights into How Plant-Derived Extracts and Compounds Can Help in the Prevention and Treatment of Keloid Disease: Established and Emerging Therapeutic Targets. | Int J Mol Sci | 2024 | 38279232 | PubTator, text mining | PubMed |
| 14-3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer. | Cell Commun Signal | 2024 | 38279176 | PubTator, text mining | PubMed |
| Unveiling the Anticancer Mechanism of Echinops davuricus: Isolation and Evaluation of AKR1B10 Inhibitors. | Chem Biodivers | 2024 | 38270380 | PubTator, text mining | PubMed |
| Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings. | Cancers (Basel) | 2024 | 38254805 | PubTator, text mining | PubMed |
| Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2024 | 38250307 | PubTator, text mining | PubMed |
| Long-read transcriptome landscapes of primary and metastatic liver cancers at transcript resolution. | Biomark Res | 2024 | 38185659 | PubTator, text mining | PubMed |
| BAF45D-binding to HOX genes was differentially targeted in H9-derived spinal cord neural stem cells. | Sci Rep | 2024 | 38168763 | PubTator, text mining | PubMed |
| Identification of potential miR‑155 target genes in epidermal immune microenvironment of atopic dermatitis patients and their inflammatory effects on HaCaT cells. | Exp Ther Med | 2024 | 38125354 | PubTator, text mining | PubMed |
| Bioinformatics and machine learning driven key genes screening for hepatocellular carcinoma. | Biochem Biophys Rep | 2024 | 38107663 | PubTator, text mining | PubMed |
| Modes and model building in SHELXE. | Acta Crystallogr D Struct Biol | 2024 | 38088896 | PubTator, text mining | PubMed |
| Exploring the Effects of Endocrine-Disrupting Chemicals and miRNA Expression in the Pathogenesis of Endometriosis by Unveiling the Pathways: a Systematic Review. | Reprod Sci | 2024 | 38036864 | PubTator, text mining | PubMed |
| AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway. | Oncol Lett | 2024 | 38034486 | PubTator, text mining | PubMed |
| Development of AKR1B10 inhibitors from Ajuga nipponensis based on diseases and targets. | Fitoterapia | 2024 | 37952764 | PubTator, text mining | PubMed |
| Repurposing of Strychnine as the Potential Inhibitors of Aldo-keto Reductase Family 1 Members B1 and B10: Computational Modeling and Pharmacokinetic Analysis. | Protein J | 2024 | 37940790 | PubTator, text mining | PubMed |
| Synergistic effects of COVID-19 and Pseudomonas aeruginosa in chronic obstructive pulmonary disease: a polymicrobial perspective. | Mol Cell Biochem | 2024 | 37129767 | PubTator, text mining | PubMed |
| Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches. | Mol Divers | 2024 | 36670282 | PubTator, text mining | PubMed |
| Whole genome sequencing reveals population diversity and variation in HIV-1 specific host genes. | Front Genet | 2023 | 38179408 | PubTator, text mining | PubMed |
| Subjective behavioral measures in myopic and pre-myopic children before and after the COVID lockdown. | Front Med (Lausanne) | 2023 | 38155664 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57016/papers?page=8